HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTS ...Middle East

The Keynote Address, entitled "Beyond Ketamine: Combined Interventional Treatment of Suicidal Depression and PTSD," will be presented at 10:30AM PT on Sunday January 12th, 2025 Prof. David Feifel MD PHD, designated Chief Medical Innovation Officer of HOPE and Founder of the Kadima...

Hence then, the article about hope therapeutics inc and nrx pharmaceuticals inc nasdaq nrxp announce dr jonathan javitt and dr david feifel to present keynote address beyond ketamine monotherapy combined interventional treatment of suicidal depression and pts was published today ( Tuesday 07/01/2025 - 04:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTS )

Also on site :

• X GAMES AND MOONPAY ANNOUNCE LANDMARK TITLE PARTNERSHIP USHERING IN A NEW ERA OF ACTION SPORTS
• Trump is breaking the old global order; allies brace for economic risks
• Trump has ramped up lawsuits against the media. Here’s where they stand